QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy

被引：0
|
作者：
Russell, Anthony S. [1 ]
Lisboa, Luiz [2 ]
Dos Santos, Marla F. [3 ]
Kumar, Deepali [4 ]
Humar, Atul [4 ]
机构：
[1] Univ Alberta, Heritage Med Ctr 562, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Med, Edmonton, AB T6G 2E1, Canada
[3] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[4] Univ Alberta, Alberta Transplant Inst, Katz Ctr Hlth Res 6 030, Edmonton, AB T6G 2E1, Canada
来源：
CLINICAL RHEUMATOLOGY | 2013年 / 32卷 / 11期
关键词：
Abatacept; Cell-mediated immunity; Rheumatoid arthritis; T-CELL; COSTIMULATION; VACCINATION; RESPONSES; BLOCKADE;
D O I：
10.1007/s10067-013-2298-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1657 / 1659
页数：3
相关论文
共 50 条
  • [41] The Impact of Hormone Replacement Therapy on Humoral and Cell-mediated Immune Responses In Vivo in Post-menopausal Women with Rheumatoid Arthritis
    d'Elia, H. Forsblad
    Carlsten, H.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008, 68 (06) : 661 - 667
  • [42] Monitoring of cell-mediated immunity parameters in RA patients on long-term anti-TNF therapy
    Blazickova, S
    Lackovic, V
    Mateicka, F
    Poprac, P
    Rovensky, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 128 - 129
  • [43] CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
    Jennifer Pieper
    Jessica Herrath
    Sukanya Raghavan
    Khalid Muhammad
    Ronald van Vollenhoven
    Vivianne Malmström
    BMC Immunology, 14
  • [44] CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
    Pieper, Jennifer
    Herrath, Jessica
    Raghavan, Sukanya
    Muhammad, Khalid
    van Vollenhoven, Ronald
    Malmstrm, Vivianne
    BMC IMMUNOLOGY, 2013, 14
  • [45] Tumor necrosis Factor (TNF) Bioactivity at the site of an acute cell-Mediated immune response is Preserved in rheumatoid arthritis Patients responding to anti-TNF Therapy
    Byng-Maddick, Rachel
    Turner, Carolin T.
    Pollara, Gabriele
    Ellis, Matthew
    Guppy, Naomi J.
    Bell, Lucy C. K.
    Ehrenstein, Michael R.
    Noursadeghi, Mahdad
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [46] Characteristics of rheumatoid arthritis patients initiating therapy with abatacept, other biologics, and non-biologic disease-modifying anti-rheumatic drugs
    Hoffman, Veena
    Simon, Teresa A.
    Liu, Nan
    Lin, Nancy D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 278 - 278
  • [47] DISSOCIATION BETWEEN INVIVO AND INVITRO ASSAYS OF CELL-MEDIATED-IMMUNITY (CMI) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA)
    ANDRIANAKOS, AA
    SHARP, JT
    LIDSKY, MD
    PERSON, D
    MERIKAS, GE
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1975, 4 : 1406 - 1406
  • [48] Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy
    Weinberg, A
    Wiznia, AA
    LaFleur, BJ
    Shah, S
    Levin, MJ
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (02): : 267 - 270
  • [49] STUDY OF CORRELATION OF B-CELL LEVEL AND PROGRESSION OF BONE DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING RITUXIMAB THERAPY
    Kudryavtseva, A.
    Lukina, G.
    Smirnov, A.
    Glukhova, S.
    Aronova, E.
    Gridneva, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1447 - 1447
  • [50] Th17/Tfh Cell Predict Disease Severity in Rheumatoid Arthritis Patients Receiving TNF Inhibitor Therapy
    Singh, Deepika
    Henkel, Matthew
    Feng, Juan
    Lyons, Jason
    Eng, Heather
    Moreland, Larry W.
    McGeachy, Mandy J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345